VoluSense develops mask-free systems for lung function evaluation. Our first product is for hospitalised infants.

VoluSense Pediatrics has not been released for marketing in the USA and has not yet been vetted or approved by the US Food and Drug Administration. VoluSense is in the preparation stage for FDA review of the product. We welcome collaboration queries from research hospitals.

Follow us: